Chickenpox vaccine reduces deaths

Deaths related to varicella (chicken pox) have dropped 88% in the 12 years since the vaccine became standard for kids, according to findings were published in the journal Pediatrics. Though deaths from the disease are rare, in some cases it can lead to bacterial infections, brain swelling or pneumonia, notes Reuters.

Prior to mandatory vaccination, there were 0.41 chickenpox-related deaths per million; that number dropped to just 0.05 deaths per million by the mid-2000s. In 2006 the CDC recommended that children receive two shots before the age of 6 rather than just one on research that showed the double dose was more effective at preventing the disease.

"Our analysis documents the impressive impact on varicella mortality of the U.S. vaccination program, largely during a period when only one dose was administered," the researchers noted, as quoted by Reuters. "With the current two-dose program, there is potential that these most severe outcomes of a vaccine-preventable disease could be eliminated."

- read this article for more

Suggested Articles

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.